Skip to main content
. Author manuscript; available in PMC: 2016 May 23.
Published in final edited form as: Endocr Pract. 2010 Nov-Dec;16(Suppl 3):1–37. doi: 10.4158/ep.16.s3.1

Table 15.

Indications for Bone Mineral Density Testing

All women 65 y of age or older
All postmenopausal women
    With a history of fracture(s) without major trauma after age 40 to 45 y
    With osteopenia identified radiographically
    Starting or taking long-term systemic glucocorticoid therapy (≥3 mo)
Other perimenopausal or postmenopausal women with risk factors for
  osteoporosis if willing to consider pharmacologic interventions
    Low body weight (<127 lb or body mass index <20 kg/m2)
    Ever use of long-term systemic glucocorticoid therapy (≥3 mo)
    Family history of osteoporotic fracture
    Early menopause
    Current smoking
    Excessive consumption of alcohol
Secondary osteoporosis (see Table 9)